CAMPAIGN FOR TOBACCO-FREE KIDS: Tobacco-Free Kids Supports Gov. Brown's Call to Stop the Sale of All Flavored E-Cigarettes
Statement of Matthew L. Myers, President, Campaign for Tobacco-Free Kids
SFATA: Smoke-Free Alternatives Trade Association and Coalition of Vapor Businesses & State Associations Granted Motion to Intervene in American Association of Pediatrics v FDA
Big Win for Vapor Industry: Can Now Appeal PMTA Deadline
U.S. FDA: Statement on consumer warning to stop using THC vaping products amid ongoing investigation into lung illnesses
Statement from Acting FDA Commissioner Ned Sharpless, M.D., on consumer warning to stop using THC vaping products amid ongoing investigation into lung illnesses
AMERICAN COLLEGE OF CHEST PHYSICIANS: Smokers have more blood clots in the lung, leading to higher hospital readmission rates
Patients with lung blood clots who smoke are more likely to be readmitted for lung blood clots than nonsmokers, according to Kam Sing Ho, MD, from Mount Sinai St. Luke's and Mount Sinai West in New York City, who will present the study findings at the CHEST Annual Meeting 2019 in New Orleans.
From August 29-31, 2019 China (Shenzhen) International Vape Expo, known as RHBVE, has been held by Reed Huabo Exhibition. During the three days, there were over 150 vape brands exhibiting at the show, attracting thousands of E-cig distributors, wholesalers, vape stores, traders, retailers, E-commerce, Tobacco companies, gift company etc. from 23 countries or area over the world.
The U.S. Food and Drug Administration announced today that, for the first time, it has authorized the marketing of products through the modified risk tobacco product (MRTP) pathway.
FDA Authorizes Company to State that Use of General Snus Instead of Cigarettes Puts Users at a Lower Risk of Mouth Cancer, Heart Disease, Lung Cancer, Stroke, Emphysema and Chronic Bronchitis
ACHIEVE LIFE SCIENCES: Announces Presentation of Cytisinicline Data at Society for Research on Nicotine & Tobacco Oceania (SRNT-O) Inaugural Conference
Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, today announced that data from the Phase 2b ORCA-1 trial will be presented at the SRNT-O Inaugural Conference.
Aroma Bit, Inc. (Representative Director & CEO: Shunichiro Kuroki, headquarters: Chuo-ku, Tokyo, hereinafter "Aroma Bit"), a company which plans and develops compact odor imaging sensors and innovative services using these sensors, has undertaken an third-party allocation of new shares, up to 350 million yen in total, with Japan Tobacco Inc.
The Land Transportation Franchising and Regulatory Board (LTFRB), heeding the directive of the Department of Health (DOH), has reiterated its ban on smoking cigarettes and e-cigarettes in public utility vehicles (PUVs) amid reports of exploding vaping devices.